Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Karyopharm Therapeutics Inc. (KPTI)

« Back to company index

KPTI Chatter Timeline

Stock Ticker for KPTI

Most Active Tweeters for KPTI

UserTweets
@DueDoctor 17
@Tickeron 15
@FlashAlert_me 13
@InsiderAlerts4U 6
@StocksoftheDay_ 6

Recent Tweets for KPTI

alerts_real @alerts_real
$KPTI ?Top analyst price target today? ? https://t.co/CGNu8CQAXp
May 28th 2022, 1:05pm
StocksoftheDay_ @StocksoftheDay_
$KPTI News Screener Alert: The price is up after the recent publication posted about 20 hours ago .… https://t.co/Fqmgc43yUL
May 27th 2022, 5:05pm
ResearchPool @ResearchPool
$KPTI #Karyopharm Therapeutics Selinexors DisCOMFORTing Comparisons: [...] https://t.co/pp36mURHuR #equity #stocks https://t.co/My54jhlYQ9
May 27th 2022, 11:05am
Tickeron @Tickeron
$KPTI in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/JyHt1gpqC8
May 27th 2022, 10:05am
WatcherBiotech @WatcherBiotech
$KPTI This MF data has to be a positive surprise https://t.co/W0XcGOoSLe
May 27th 2022, 8:05am
1stOncology @1stOncology
#Karyopharm to Present New #Selinexor Data at the #ASCO22 $KPTI https://t.co/Plq2LcT4zh
May 27th 2022, 7:05am
Biotech2050 @Biotech2050
RT @DueDoctor: https://t.co/74HvuPHnHE $KPTI Selinexor gains Orphan Drug Status for Myelofibrosis Not huge news but pretty great timing.…
May 27th 2022, 4:05am
Biotech2050 @Biotech2050
RT @Karyopharm: Karyopharm $KPTI to Present New Data at the 2022 American Society of Clinical Oncology Annual Meeting #ASCO22 Learn More…
May 27th 2022, 4:05am
DueDoctor @DueDoctor
https://t.co/74HvuPHnHE $KPTI Selinexor gains Orphan Drug Status for Myelofibrosis Not huge news but pretty great… https://t.co/B5pb7qGJ8r
May 27th 2022, 4:05am
Tickeron @Tickeron
$KPTI enters an Uptrend because Momentum Indicator exceeded the 0 level on May 25, 2022. View odds for this and oth… https://t.co/d4VC3ndWZT
May 27th 2022, 2:05am
Tickeron @Tickeron
Is this good for your portfolio? $KPTI Stochastic Oscillator left the overbought zone. #KaryopharmTherapeutics… https://t.co/STzh46VkmW
May 27th 2022, 1:05am
Tickeron @Tickeron
How does this make you feel? $KPTI entered Uptrend as Momentum indicator ascends above 0 level.… https://t.co/TxVFV0Ibi2
May 27th 2022, 12:05am
MarcJacksonLA @MarcJacksonLA
$KPTI Karyopharm to Present New Selinexor Data at the 2022 American Society of Clinical Oncology Annual Meeting https://t.co/1HlDIj99UE
May 26th 2022, 10:05pm
Karyopharm @Karyopharm
Karyopharm $KPTI to Present New Data at the 2022 American Society of Clinical Oncology Annual Meeting #ASCO22 Lea… https://t.co/Zx77jvjCBP
May 26th 2022, 9:05pm
StockNewsBot2 @StockNewsBot2
$KPTI Karyopharm to Present New Selinexor Data at the 2022 American Society of Clinical Oncology Annual Meeting https://t.co/SVKqgqZAYc
May 26th 2022, 9:05pm
newsfilterio @newsfilterio
Karyopharm to Present New Selinexor Data at the 2022 American Society of Clinical Oncology Annual Meeting $KPTI https://t.co/MDEgrXglx9
May 26th 2022, 9:05pm
FastestAlert @FastestAlert
$KPTI Karyopharm To Present New Selinexor Data At The 2022 American Society Of Clinical Oncology Annual Meeting Stock News Alerts In Bio
May 26th 2022, 9:05pm
stock_titan @stock_titan
$KPTI Karyopharm to Present New Selinexor Data at the 2022 American Society of Clinical Oncology Annual Meeting https://t.co/x5Iv0aTL9C
May 26th 2022, 9:05pm
MarcJacksonLA @MarcJacksonLA
$KPTI The European Myeloma Network and Karyopharm Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-… https://t.co/F98mb0fWGG
May 26th 2022, 7:05pm
thudderwicks @thudderwicks
$KPTI wins FDA’s Orphan Drug status for leading asset in myelofibrosis https://t.co/pdYAIwc2HI
May 26th 2022, 6:05pm
THEHOOKUP15 @THEHOOKUP15
Karyopharm wins FDA’s Orphan Drug status for leading asset in myelofibrosis #fdaapproval #fda #stocks #news $kpti https://t.co/fzykDz37wE
May 26th 2022, 5:05pm
MarketCurrents @MarketCurrents
$KPTI - Karyopharm wins FDA’s Orphan Drug status for leading asset in myelofibrosis https://t.co/rnWgUZSBaD
May 26th 2022, 5:05pm
Tickeron @Tickeron
$KPTI's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/NaRXTPiCNO
May 26th 2022, 2:05am
ShogunTrade @ShogunTrade
$KPTI Stock Trading Ideas | Awaiting Buy Signal. Start Free Trial at https://t.co/6vnULU2sSf https://t.co/WSZOyTDZAZ
May 25th 2022, 2:05pm
Karyopharm @Karyopharm
The European Myeloma Network and Karyopharm $KPTI Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-… https://t.co/cPgMI0OmSI
May 25th 2022, 1:05pm
StockTraderHub @StockTraderHub
$KPTI - The European Myeloma Network and Karyopharm Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-031 Study
May 25th 2022, 1:05pm
Briefingcom @Briefingcom
$KPTI: Karyopharm Therapeutics: The European Myeloma Network and Karyopharm Announce Dosing of First Patient in... https://t.co/kaLZ4rjJ70
May 25th 2022, 1:05pm
MarketCurrents @MarketCurrents
$KPTI $BMY - Karyopharm begins dosing in late-stage study of selinexor combo therapy for multiple myeloma https://t.co/QreTTd2IBu
May 25th 2022, 12:05pm
StocksoftheDay_ @StocksoftheDay_
$KPTI News Screener Alert: The price is down after the recent publication posted about 1 hour ago .… https://t.co/R8o3Sub7Wy
May 25th 2022, 12:05pm
thudderwicks @thudderwicks
$KPTI Phase 3 study evaluating an all oral regimen of selinexor in combination with pomalidomide and low-dose dexam… https://t.co/B8HpP21LfV
May 25th 2022, 11:05am
thudderwicks @thudderwicks
$KPTI doses first patient in EMN29/XPORT-MM-031 study https://t.co/c7vDkc6DLn
May 25th 2022, 11:05am
FastestAlert @FastestAlert
$KPTI The European Myeloma Network And Karyopharm Announce Dosing Of First Patient In Collaborative EMN29/XPORT-MM-… https://t.co/Vp3JCzvEiT
May 25th 2022, 11:05am
StockNewsBot2 @StockNewsBot2
$KPTI The European Myeloma Network and Karyopharm Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-… https://t.co/n97X5PcgrO
May 25th 2022, 11:05am
stock_titan @stock_titan
$KPTI The European Myeloma Network and Karyopharm Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-… https://t.co/OvfSXWPMOA
May 25th 2022, 11:05am
WebChronicleTo1 @WebChronicleTo1
$KPTI The European Myeloma Network and Karyopharm Announce Dosing of First Patient in Collaborative EMN29/XPORT-MM-… https://t.co/ovzHRrbeok
May 25th 2022, 11:05am
BestoTrading @BestoTrading
$KPTI Awaiting Buy Signal, chart by UltraAlgo. Get started for free at https://t.co/mOw8pmbZto https://t.co/KWaonU3Xb8
May 24th 2022, 3:05pm
StocksoftheDay_ @StocksoftheDay_
$KPTI News Screener Alert: The price is up after the recent publication posted about 18 hours ago .… https://t.co/AGzd7TCZvU
May 23rd 2022, 8:05pm
investor_feed @investor_feed
$KPTI 8-K Karyopharm Therapeutics (23 May, 4:06pm) ? Departure of Directors or Certain Officers; Election of D… https://t.co/nN7o9YVuuT
May 23rd 2022, 8:05pm
FlashAlert_me @FlashAlert_me
$KPTI [15s. delayed] filed form 8-K on May 23, 16:06:16 https://t.co/7yWHD4g5EC
May 23rd 2022, 8:05pm
_Jamison_Gaddy @_Jamison_Gaddy
$KPTI close over $6 and could see a short term rally
May 23rd 2022, 5:05pm
ShogunTrade @ShogunTrade
$KPTI Stock Trading Ideas | Awaiting Buy Signal. Learn more at https://t.co/6vnULU2sSf https://t.co/2AtauWV6xM
May 23rd 2022, 2:05pm
Tickeron @Tickeron
$KPTI in Uptrend: Stochastic indicator leaves oversold zone. View odds for this and other indicators:… https://t.co/B7zS2VgNlL
May 23rd 2022, 12:05pm
FlashAlert_me @FlashAlert_me
$KPTI [15s. delayed]: Issued Press Release on May 22, 22:00:00: Antengene Announces First Patient Dosed in the Phas… https://t.co/deO67LsHKY
May 23rd 2022, 2:05am
Shingpeng1 @Shingpeng1
$KPTI Top analyst price target for the next week https://t.co/BLSaZMx6ze
May 22nd 2022, 10:05am
DueDoctor @DueDoctor
@awisejester I've written a lot on $KPTI, most of it is on r/KPTI. Godspeed! Dr. DD https://t.co/iC8R6oSZd6
May 22nd 2022, 12:05am
DueDoctor @DueDoctor
So for those of you asking, yes, I'm riding, and when $KPTI gets bought out in the next 9-18 months, I expect at le… https://t.co/SSwybntCdw
May 21st 2022, 11:05pm
DueDoctor @DueDoctor
With + EU 2nd Line CHMP Opinion, EC approval for $KPTI in 60 days, now we wait to see if the company decided for CV… https://t.co/A2LlRuBzwV
May 21st 2022, 11:05pm
DueDoctor @DueDoctor
+ Buyout $KPTI signal - Compensation switched to options... for every single person on the board - check the SEC Fo… https://t.co/UEhVwHipZ8
May 21st 2022, 11:05pm
InsiderAlerts4U @InsiderAlerts4U
$KPTI: New Insider Filing on Karyopharm Therapeutics Inc.'s Director CHRISTY J. OLIGER: https://t.co/XWCzRlzB5S
May 21st 2022, 12:05pm
Tickeron @Tickeron
$KPTI was the market's top weekly gainer, with a +8.99% jump #KaryopharmTherapeutics #stockmarket #stock https://t.co/zFwofom3y6
May 21st 2022, 11:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.